Feature | June 10, 2014

Opti-SPECT/PET/CT: Five Different Imaging Systems Now Combined

Wide range of molecular imaging modalities is at researchers’ fingertips with a hybrid device dedicated for early-stage clinical trials

June 10, 2014 – Taking their pick, biomedical researchers can now conduct five different imaging studies in one scan with a state-of-the-art preclinical molecular imaging system that scientists unveiled during the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting.

The imaging device allows single photon emission tomography (SPECT), positron emission tomography (PET), X-ray computed tomography (CT), fluorescence and bioluminescence imaging — powerful imaging techniques that provide different information about anatomy and physiological processes happening within the body. With the Opti-SPECT/PET/CT system, SPECT or PET information details drug distribution and improves interpretation of optical data, while bioluminescence and fluorescence characterize additional tumor properties.  The tracers that are developed with the system will be used as a surgical guide for clinicians.

“We need to know as much as possible from our enemy: the tumor,” Frederik Beekman, Ph.D., explained.  Beekman is head of radiation technology and medical imaging and a professor at Delft University of Technology in Delft, The Netherlands. “This research proves that we can now obtain comprehensive data from five medical imaging systems in a single scan. It is minimally invasive and requires only a single dose of anesthesia.”

Opti-SPECT/PET/CT is built on a small scale for preclinical studies and allows scientists to use a gamut of imaging methods including high resolution nuclear medicine (SPECT and PET), radiological (CT) and optical imaging (fluorescence and bioluminescence). This means that information about organ function, structure and real-time physiological signals revealed within the light spectrum are all available in a synergistic fusion of advanced medical imaging. The hybrid system includes high-performance cameras and an on-board dark room. The molecular imaging platform could be used for new drug discovery, especially for imaging agents that could be used intraoperatively for patients undergoing cancer surgery.

To test the device, researchers imaged models and then mice in multiple studies using a fluorescent dye optical agent and a nuclear medicine imaging agent that combines a radioactive particle with a chemical drug compound. The agent is injected and then imaged as it homes in on and interacts with specific bodily functions. In this case, that function is angiogenesis, or the development of new blood vessels, which often proliferate as a tumor grows. Results of the study confirmed the imaging system’s functionality and proved that it was comparable to other add-on imaging platforms for preclinical studies.

For more information: www.snmmi.org

Related Content

UltraSPECT, 450th U.S. installation, Firelands Regional Medical Center, nuclear medicine, radiation safety
News | Nuclear Imaging| January 27, 2016
UltraSPECT Inc. has marked the 450th U.S. installation of its low-dose image processing technology for nuclear medicine...
Image Wisely, annual pledge process, medical imaging, radiation safety
News | Radiation Dose Management| January 27, 2016
Image Wisely participants must now make yearly commitments, as opposed to a one-time pledge, confirming their ongoing...
Medic Vision, SafeCT Enterprise, St. Joseph's/Candler Health System, Georgia
News | Computed Tomography (CT)| January 26, 2016
Medic Vision Imaging Solutions Ltd. announced the installation of SafeCT (computed tomography) at St. Joseph’s/Candler...
ECRI Institute, Rate This Model, medical equipment, review/rating tool
News | Business| January 25, 2016
Now, medical technology purchasers and users have an instant online forum to rate and review technologies they are...
ACC, ACR, chest pain, diagnostic imaging, emergency department, recommendations document
News | Cardiac Imaging| January 25, 2016
New recommendations from the American College of Cardiology (ACC) and the American College of Radiology (ACR) have...
Siemens, Biograph Horizon PET CT, FDA clearance
Technology | PET-CT| January 21, 2016
Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Biograph...
News | Cardiac Imaging| December 28, 2015 | Dave Fornell
December 28, 2015 — Toshiba announced Dec.
Siemens, TwinBeam Dual Energy CT, Somatom Definition, RSNA 2015
Technology | Advanced Visualization| December 21, 2015
Siemens Healthcare’s approach to delivering dose-neutral dual energy images obtained on Somatom computed tomography (CT...
GE Healthcare, Revolution CT family, EVO, RSNA 2015

The Revolution HD expands CT’̈s utility beyond simple anatomy towards tissue characterization through gemstone spectral imaging.  This image used the ASiR iterative reconstruction to create a chest, abdomen, pelvis exam at only 5.8 mSv.

Technology | Computed Tomography (CT)| December 15, 2015
The Revolution CT, Revolution HD and Revolution EVO CT scanners are now offered with a wider range of capabilities to...
Technology | Cath Lab| December 14, 2015
December 14, 2015 — The industry’s first seamless integration of interventional radiology (IR) and CT technology into
Overlay Init